The Time for Cytokine Therapeutics Is Now
We believe that cytokine therapeutics engineered to be selective and overcome their pleiotropy can fundamentally change the treatment paradigms of cancer and autoimmune / inflammatory disease.
The Pipeline to Advance Our Mission
Using our team’s cumulative expertise and our proprietary cytokine platforms, we are developing a broad, deep pipeline of selective immunotherapies against a wide range of important targets for the treatment of cancers and autoimmune / inflammatory diseases.